Mol Cancer May 2023 PMID 37226188

New opportunities for RGD-engineered metal nanoparticles in cancer.

Wei Qin, Jyoti Chandra, Mohammed A S Abourehab, Neelima Gupta, Zhe-Sheng Chen, Prashant Kesharwani, Hui-Ling Cao

Full text PDF Download social card

Mentions

Peak: 1 in May 2023

across 2 sources since May 2023

Extended reach

616

potential audience

Total likes

Video views

Mentions per month

May 2023 – Aug 2023

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions mainly affirm the publication's focus on innovative use of metal nanoparticles and RGD peptides for cancer imaging, with some posts highlighting the 'new opportunities' without delving into technical details. The tone is neutral to slightly positive, emphasizing potential, but lacking in detailed critique or exploration, which aligns with a moderate agreement and impact score.

AgreementModerate agreement

The posts generally reflect supportive views, indicating recognition of the advancements discussed in the article, though not overwhelmingly enthusiastic.

InterestModerate interest

The discussions show moderate interest, with the use of hashtags and mentions of innovative applications but lack detailed exploration.

EngagementNeutral engagement

Participants seem to acknowledge the publication but do not deeply explore its methods or broader implications, suggesting a superficial engagement.

ImpactModerate impact

The discussions hint at recognizing potential benefits of this nanotechnology in cancer imaging, though they do not articulate substantial or transformative impacts clearly.

Abstract in brief

Nanotechnology enables new advancements in bioimaging, particularly with the use of metal nanoparticles like gold and silver, which provide unique optical properties and easy customization.
RGD peptides, consisting of three amino acids, specifically target tumor cells by binding to unique integrin molecules, enhancing imaging precision.
The review emphasizes the potential of using metal nanoparticles alongside RGD peptides for non-invasive cancer imaging techniques.

Read the full abstract

All mentions

Advances in RGD-Engineered Metal Nanoparticles for Cancer Imaging

Nanotechnology enables new advancements in bioimaging, particularly with metal nanoparticles like gold and silver, which offer unique optical properties and easy customization. RGD peptides target tumor cells by binding…

Social RTCL TV · Aug 25, 2023 36 views

IronBiologyBot

@IronBiologyBot · X

RT @IronBiologyBot: New opportunities for RGD-engineered metal nanoparticles in cancer #IronBiology #BioIron #Iron https://t.co/nRzxoyLRok

Jun 1, 2023 · 1 share · 288 followers View post →